title: Bilateral hearing loss as a manifestation of neuromyelitis optica.
authors.affiliation: From Medstar Georgetown University Hospital Department of Neurology, Washington, DC. seangratton@gmail.com.
authors.forename: Sean
authors.initials: S
authors.lastname: Gratton
authors.affiliation: From Medstar Georgetown University Hospital Department of Neurology, Washington, DC.
authors.forename: Faria
authors.initials: F
authors.lastname: Amjad
authors.affiliation: From Medstar Georgetown University Hospital Department of Neurology, Washington, DC.
authors.forename: Forough
authors.initials: F
authors.lastname: Ghavami
authors.affiliation: From Medstar Georgetown University Hospital Department of Neurology, Washington, DC.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Osborne
authors.affiliation: From Medstar Georgetown University Hospital Department of Neurology, Washington, DC.
authors.forename: Carlo
authors.initials: C
authors.lastname: Tornatore
authors.affiliation: From Medstar Georgetown University Hospital Department of Neurology, Washington, DC.
authors.forename: Carlos
authors.initials: C
authors.lastname: Mora
mesh_terms: D005260:Female; D006312:Hearing Loss, Bilateral / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy*; D006320:Hearing Tests; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage / Q000494:pharmacology*; D008875:Middle Aged; D009471:Neuromyelitis Optica / Q000150:complications*; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000494:pharmacology*; D010956:Plasmapheresis / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D018696:Neuroprotective Agents; D008775:Methylprednisolone